Nalaganje...
Molecular pathology of lung cancer: clinical aspects
Discovery of tyrosine kinase inhibitor sensitizing mutations in lung cancer (LC) appears to be the main event in clinical oncology of the last decade. Activating lesions in epidermal growth factor receptor (EGFR) gene almost guarantee tumor response to gefitinib, erlotinib or afatinib.ALK translocat...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
Tomsk National Research Medical Center of the Russian Academy of Sciences
2016-02-01
|
| Serija: | Sibirskij Onkologičeskij Žurnal |
| Teme: | |
| Online dostop: | https://www.siboncoj.ru/jour/article/view/255 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|